These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27909884)

  • 1. Differential role of Wnt signaling and base excision repair pathways in gastric adenocarcinoma aggressiveness.
    Korourian A; Roudi R; Shariftabrizi A; Kalantari E; Sotoodeh K; Madjd Z
    Clin Exp Med; 2017 Nov; 17(4):505-517. PubMed ID: 27909884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells.
    Korourian A; Roudi R; Shariftabrizi A; Madjd Z
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1842-1847. PubMed ID: 28836853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy.
    Abdel-Fatah TM; Albarakati N; Bowell L; Agarwal D; Moseley P; Hawkes C; Ball G; Chan S; Ellis IO; Madhusudan S
    Breast Cancer Res Treat; 2013 Dec; 142(3):515-27. PubMed ID: 24253812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RHOA mutation in diffuse-type gastric cancer: a comparative clinicopathology analysis of 87 cases.
    Ushiku T; Ishikawa S; Kakiuchi M; Tanaka A; Katoh H; Aburatani H; Lauwers GY; Fukayama M
    Gastric Cancer; 2016 Apr; 19(2):403-411. PubMed ID: 25823974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are DNA repair factors promising biomarkers for personalized therapy in gastric cancer?
    Abdel-Fatah T; Arora A; Gorguc I; Abbotts R; Beebeejaun S; Storr S; Mohan V; Hawkes C; Soomro I; Lobo DN; Parsons SL; Madhusudan S
    Antioxid Redox Signal; 2013 Jun; 18(18):2392-8. PubMed ID: 22894650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
    Lin MT; Lin BR; Chang CC; Chu CY; Su HJ; Chen ST; Jeng YM; Kuo ML
    Int J Cancer; 2007 Jun; 120(12):2600-8. PubMed ID: 17304514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic and Pathologic Profiling of Very Well-Differentiated Gastric Adenocarcinoma of Intestinal Type: A Study With Emphasis on Diffuse-Type Transformation.
    Rokutan H; Arai Y; Kunita A; Yamasaki S; Nakamura H; Hama N; Nakayama A; Hosoda F; Totoki Y; Fujishiro M; Seto Y; Shibata T; Ushiku T
    Am J Surg Pathol; 2024 Jun; 48(6):652-661. PubMed ID: 38584451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uracil-DNA glycosylases SMUG1 and UNG2 coordinate the initial steps of base excision repair by distinct mechanisms.
    Pettersen HS; Sundheim O; Gilljam KM; Slupphaug G; Krokan HE; Kavli B
    Nucleic Acids Res; 2007; 35(12):3879-92. PubMed ID: 17537817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and significance of RhoA and NF-ΚB in human gastric carcinoma].
    Su XJ; Tang ZF; Li Q; Li HL; Li LL; Liu M; Zhou YN
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):276-9. PubMed ID: 21575498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathobiological behaviors and prognosis associated with Japanese gastric adenocarcinomas of pure WHO histological subtypes.
    Zheng HC; Zheng YS; Xia P; Xu XY; Xing YN; Takahashi H; Guan YF; Takano Y
    Histol Histopathol; 2010 Apr; 25(4):445-52. PubMed ID: 20183797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced MUTYH, MTH1, and OGG1 expression and TP53 mutation in diffuse-type adenocarcinoma of gastric cardia.
    Kohno Y; Yamamoto H; Hirahashi M; Kumagae Y; Nakamura M; Oki E; Oda Y
    Hum Pathol; 2016 Jun; 52():145-52. PubMed ID: 26980051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RHOA mutations and CLDN18-ARHGAP fusions in intestinal-type adenocarcinoma with anastomosing glands of the stomach.
    Hashimoto T; Ogawa R; Tang TY; Yoshida H; Taniguchi H; Katai H; Oda I; Sekine S
    Mod Pathol; 2019 Apr; 32(4):568-575. PubMed ID: 30425335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy is related to the hedgehog signaling pathway in human gastric adenocarcinoma: prognostic significance of Beclin-1 and Gli2 expression in human gastric adenocarcinoma.
    Won KY; Kim GY; Lim SJ; Sung JY; Kim YW; Park YK; Lee J; Choi HS
    Pathol Res Pract; 2015 Apr; 211(4):308-15. PubMed ID: 25512258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type.
    Nomura R; Saito T; Mitomi H; Hidaka Y; Lee SY; Watanabe S; Yao T
    Hum Pathol; 2014 Dec; 45(12):2488-96. PubMed ID: 25288233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
    Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
    Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathway.
    Suh JH; Won KY; Kim GY; Bae GE; Lim SJ; Sung JY; Park YK; Kim YW; Lee J
    Int J Clin Exp Pathol; 2015; 8(11):14608-18. PubMed ID: 26823784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEACAM5 has different expression patterns in gastric non-neoplastic and neoplastic lesions and cytoplasmic staining is a marker for evaluation of tumor progression in gastric adenocarcinoma.
    Liu JN; Wang HB; Zhou CC; Hu SY
    Pathol Res Pract; 2014 Oct; 210(10):686-93. PubMed ID: 25042385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
    Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
    Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric Cancer With Primitive Enterocyte Phenotype: An Aggressive Subgroup of Intestinal-type Adenocarcinoma.
    Yamazawa S; Ushiku T; Shinozaki-Ushiku A; Hayashi A; Iwasaki A; Abe H; Tagashira A; Yamashita H; Seto Y; Aburatani H; Fukayama M
    Am J Surg Pathol; 2017 Jul; 41(7):989-997. PubMed ID: 28505005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant Pim-3 expression is involved in gastric adenoma-adenocarcinoma sequence and cancer progression.
    Zheng HC; Tsuneyama K; Takahashi H; Miwa S; Sugiyama T; Popivanova BK; Fujii C; Nomoto K; Mukaida N; Takano Y
    J Cancer Res Clin Oncol; 2008 Apr; 134(4):481-8. PubMed ID: 17876606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.